Neurology News
Rare Disease Day and the Importance of Neurologic Involvement
21 Feb 2025
"Awareness and Care Practices for Rare Neurologic Diseases Among Senior Neurologists: A Global Survey" by the WFN Specialty Group on Rare Disease helps to mark Rare Disease Day, on February 28th
WFN-AOAN e-Learning Day on Movement Disorders now available on demand
20 Feb 2025
The WFN-AOAN 2025 e-learning day on Movement Disorders is now available through video on demand on the WFN e-Learning Hub.
Should antinuclear antibodies (ANA) be used to screen for connective tissue disease in neurological patients?
18 Feb 2025
Patients with connective tissue diseases (CTD) can have a wide range of neurological manifestations. Neurological complaints may be the presenting symptom of CTD. Therefore, screening for CTD using anti-nuclear antibodies (ANA) is a common practice. However, due to the abundance of positive ANA in a healthy population, interpretation of the results may be complex.
Diagnosing progressive multifocal leukoencephalopathy
6 Feb 2025
Positive predictive value of CSF JC virus quantitative PCR and importance of recognizing suggestive neuroimaging findings.
The World Federation of Neurology Digital Neurology Update (WNU)
30 Jan 2025
The World Federation of Neurology Digital Neurology Update (WNU) is a concise two-day update on some of the most frequent neurological disorders, delivered by high-level scientific speakers, who are often proposed by specialist societies, and who teach courses that educate attendees on important and frequent clinical aspects.
Awareness and care practices for rare neurologic diseases among senior neurologists: A global survey
27 Jan 2025
Rare neurologic diseases (RNDs) are difficult to diagnose and treat due to their low prevalence and complex nature. This survey evaluated awareness and current care status of RNDs among esteemed neurologists affiliated with the World Federation of Neurology (WFN).
Challenges and Risks in Transitioning CIDP Treatment to FcRn Inhibitors
15 Jan 2025
Switching from IVIG to FcRn inhibitors like efgartigimod in managing CIDP presents significant challenges, including the risk of early disease deterioration and mixed patient responses.
Current status of fluid biomarkers for early Alzheimer's disease and FDA regulation implications
27 Dec 2024
Many changes can now be seen in the development and use of tests, especially those incorporating fluid biomarkers, to diagnose Alzheimer's disease (AD), a devastating disease caused by the progressive but rapid degeneration of cortical tissue.
Central African Neurology Takes Center Stage
23 Dec 2024
The Hybrid Presidential Symposium of the Fourth Congress of the Cameroon Academy of Neurology.
Neuroepidemiology: Basic concepts and population surveys
23 Dec 2024
The practice of modern neurology is based on research evidence. Research evidence is constructed by teams of investigators throughout the world, from Tokyo to Buenos Aires, from Sidney to Vancouver, from New York to Rome. These investigators use research methods and tools to design and conduct their studies.
Web design by Tribal Systems